Search

Your search keyword '"Marchbank KJ"' showing total 68 results

Search Constraints

Start Over You searched for: Author "Marchbank KJ" Remove constraint Author: "Marchbank KJ"
68 results on '"Marchbank KJ"'

Search Results

2. Germline selection shapes human mitochondrial DNA diversity

3. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

5. Large expert-curated database for benchmarking document similarity detection in biomedical literature search

6. Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort.

7. Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

9. Contribution of animal models to the mechanistic understanding of Alternative Pathway and Amplification Loop (AP/AL)-driven Complement-mediated Diseases.

10. A novel method for real-time analysis of the complement C3b:FH:FI complex reveals dominant negative CFI variants in age-related macular degeneration.

11. Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy.

12. Homodimeric Minimal Factor H: In Vivo Tracking and Extended Dosing Studies in Factor H Deficient Mice.

13. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.

14. Insights Into the Structure-Function Relationships of Dimeric C3d Fragments.

15. The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

16. Murine Factor H Co-Produced in Yeast With Protein Disulfide Isomerase Ameliorated C3 Dysregulation in Factor H-Deficient Mice.

17. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.

18. Functional Characterization of Rare Genetic Variants in the N-Terminus of Complement Factor H in aHUS, C3G, and AMD.

19. Editorial: Autoantibodies in Kidney Diseases.

20. Thermal resilience of ensilicated lysozyme via calorimetric and in vivo analysis.

21. Successful simultaneous liver-kidney transplantation for renal failure associated with hereditary complement C3 deficiency.

22. Ensilicated tetanus antigen retains immunogenicity: in vivo study and time-resolved SAXS characterization.

23. Rare Genetic Variants in Complement Factor I Lead to Low FI Plasma Levels Resulting in Increased Risk of Age-Related Macular Degeneration.

24. Long-term outcomes and response to treatment in diacylglycerol kinase epsilon nephropathy.

25. Large-Scale Whole-Genome Sequencing Reveals the Genetic Architecture of Primary Membranoproliferative GN and C3 Glomerulopathy.

26. Hyperfunctional complement C3 promotes C5-dependent atypical hemolytic uremic syndrome in mice.

27. Utilization of Staphylococcal Immune Evasion Protein Sbi as a Novel Vaccine Adjuvant.

29. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.

30. A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice.

31. Modulation of the Alternative Pathway of Complement by Murine Factor H-Related Proteins.

32. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.

33. Thermal stability, storage and release of proteins with tailored fit in silica.

34. Thrombotic Microangiopathy in Inverted Formin 2 - Mediated Renal Disease.

35. A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.

36. Selectivity of C3-opsonin targeted complement inhibitors: A distinct advantage in the protection of erythrocytes from paroxysmal nocturnal hemoglobinuria patients.

37. The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.

38. An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.

39. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL.

40. Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS).

41. Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.

42. A novel method for direct measurement of complement convertases activity in human serum.

43. Standardisation of the factor H autoantibody assay.

44. Factor H autoantibodies in membranoproliferative glomerulonephritis.

45. Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.

46. Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?

47. Mice expressing human CR1/CD35 have an enhanced humoral immune response to T-dependent antigens but fail to correct the effect of premature human CR2 expression.

48. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.

49. Complement factor h autoantibodies and age-related macular degeneration.

50. Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1).

Catalog

Books, media, physical & digital resources